Goldman Sachs’s Direxion Daily S&P Biotech Bull 3X Shares LABU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Sell |
50,074
-1
| -0% | -$57 | ﹤0.01% | 3192 |
|
|
2025
Q1 | $3.05M | Hold |
50,075
| – | – | ﹤0.01% | 3091 |
|
|
2024
Q4 | $4.51M | Sell |
50,075
-4
| -0% | -$360 | ﹤0.01% | 2933 |
|
|
2024
Q3 | $6.45M | Sell |
50,079
-19
| -0% | -$2.45K | ﹤0.01% | 2582 |
|
|
2024
Q2 | $5.68M | Buy |
+50,098
| New | +$5.68M | ﹤0.01% | 2520 |
|
|
2024
Q1 | – | Sell |
-9,741
| Closed | -$1.19M | – | 4849 |
|
|
2023
Q4 | $1.19M | Buy |
+9,741
| New | +$1.19M | ﹤0.01% | 3528 |
|
|
2023
Q3 | – | Sell |
-16,863
| Closed | -$99.8K | – | 4854 |
|
|
2023
Q2 | $99.8K | Buy |
+16,863
| New | +$99.8K | ﹤0.01% | 4564 |
|
|
2023
Q1 | – | Sell |
-42,633
| Closed | -$301K | – | 5193 |
|
|
2022
Q4 | $301K | Buy |
+42,633
| New | +$301K | ﹤0.01% | 4351 |
|
|
2022
Q3 | – | Sell |
-10,994
| Closed | -$74K | – | 5583 |
|
|
2022
Q2 | $74K | Buy |
+10,994
| New | +$74K | ﹤0.01% | 5194 |
|
|
2019
Q3 | – | Sell |
-8,602
| Closed | -$432K | – | 4289 |
|
|
2019
Q2 | $432K | Buy |
+8,602
| New | +$432K | ﹤0.01% | 3584 |
|